← Back to Search

Thermal Management

aggressive warming for Hypothermia (PROTECT Trial)

N/A
Waitlist Available
Research Sponsored by The Cleveland Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from the end of surgery to 30 days after surgery
Awards & highlights

PROTECT Trial Summary

This trial will compare the effects of routine care vs. aggressive warming on cardiovascular complications.

Eligible Conditions
  • Hypothermia
  • Perioperative Care
  • Surgery Complications
  • Myocardial Injury

PROTECT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from the end of surgery to 30 days after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and from the end of surgery to 30 days after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants With a Composite Outcome Consisted of Myocardial Injury After Non-cardiac Surgery (MINS), Non-fatal Cardiac Arrest, and All-cause Mortality
Secondary outcome measures
Deep or Organ-space Surgical Site Infection
Duration of Hospitalization
Number of Patients Requiring Intraoperative Transfusion
+1 more

PROTECT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Aggressive thermal managementExperimental Treatment1 Intervention
Patients assigned to aggressive warming will be pre-warmed with a full-body Bair Hugger or Bair Paws cover for ≈30 minutes before induction of anesthesia. The warmer will initially be set to "high" which corresponds to ≈43°C. It will be subsequently adjusted to make patients feel warm, but not uncomfortably so. Patients will be aggressively warmed during surgery to a target intraoperative core temperature between 37 and 37.5°C, using an Multi-Position Upper Body and Full Access Underbody Warming Blankets forced-air covers when clinically practical. All intravenous fluids will be warmed to body temperature.
Group II: Routine thermal managementActive Control1 Intervention
Patients assigned to routine thermal management will not be pre-warmed and ambient intraoperative temperature will be maintained near 20°C per routine. Only transfused blood will be warmed. An Multi-Position Upper Body Warming Blanket forced-air cover will be positioned over an appropriate non-operative site, but will not initially be activated. Should core temperature decrease to 35.5°C, the warmer will be activated as necessary to prevent core temperature from decreasing further.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
aggressive warming
2017
N/A
~5060

Find a Location

Who is running the clinical trial?

The Cleveland ClinicLead Sponsor
1,030 Previous Clinical Trials
1,360,502 Total Patients Enrolled
6 Trials studying Hypothermia
158 Patients Enrolled for Hypothermia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~625 spots leftby May 2025